文献速递耳科与耳神经

成人咽鼓管功能障碍的医疗资源利用与处方模式

Health Care Utilization and Prescribing Patterns for Adult Eustachian Tube Dysfunction.
PubMed 文献 · Otolaryngol Head Neck Surg · 2019-02-05

这项横断面研究基于Truven Health MarketScan数据库(2010-2014年),分析成人咽鼓管功能障碍(ETD)患者的就诊与处方模式。共纳入1,298,987例ETD患者,其中11%为慢性;92%以上在门诊就诊,慢性ETD多由耳鼻咽喉科(57%)诊治,急性ETD多由全科医学(49%)诊治;530,146例(53.7%)患者至少接受1次处方,慢性ETD最常见处方为鼻内糖皮质激素(22%)、抗生素(22%)、口服糖皮质激素(13%)和镇痛药(6%)。

要点

  • 慢性ETD多由耳鼻咽喉科(57%)诊治,急性ETD多由全科医学(49%)诊治。
  • 53.7%患者至少接受1次处方,慢性ETD常用鼻内糖皮质激素、抗生素和口服糖皮质激素。

核心结论

  • 成人ETD常由多种医疗提供者使用多种药物类别治疗,了解这些实践的潜在不良反应和费用应成为优先事项。

研究设计与样本

  • 横断面研究,使用Truven Health MarketScan数据库(2010-2014年)分析≥18岁、诊断为ETD、渗出性中耳炎或鼓膜内陷的患者就诊记录,排除近期急性上呼吸道感染、头颈癌或放疗相关就诊;急性ETD(<3个月)和慢性ETD(≥3个月)为亚组。

主要发现

  • 共诊断ETD患者1,298,987例,其中11%为慢性。
  • 92%以上患者就诊于门诊,慢性ETD最常见由耳鼻咽喉科(57%)诊治,急性ETD最常见由全科医学(49%)诊治。
  • 530,146例(53.7%)患者接受至少1次处方。
  • 慢性ETD最常见处方为鼻内糖皮质激素(22%)、抗生素(22%)、口服糖皮质激素(13%)和镇痛药(6%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Eustachian tube dysfunction (ETD) prompts >2 million adult visits in the United States annually. While disease prevalence and health care utilization are established for children, practice patterns for adults remain unknown. Our objective was to determine national resource utilization for adult ETD. STUDY DESIGN: Cross-sectional study. SETTING: National database sample. SUBJECTS AND METHODS: The Truven Health MarketScan Databases (2010-2014) analytic cohort included health care encounters of patients ≥18 years of age with a diagnosis of ETD, otitis media with effusion, or tympanic membrane retraction. Visits associated with recent diagnoses of acute upper respiratory infection, head and neck cancer, or radiation therapy were excluded. Acute ETD (<3 months) and chronic ETD (≥3 months) were subgroups. Medication usage was quantified by class. RESULTS: ETD was diagnosed for 1,298,987 patients, 11% of which was chronic. Over 92% of patients were seen in outpatient clinics, most often by otolaryngology (57%) for chronic ETD and by general medicine (49%) for acute ETD. Medications were frequently utilized, as 530,146 (53.7%) patients received ≥1 prescription. Top prescriptions for chronic ETD included intranasal corticosteroids (22%), antibiotics (22%), oral corticosteroids (13%), and analgesics (6%). The overall annual cost of prescribed medications associated with visits in which either acute or chronic ETD was diagnosed exceeded $8.5 million for a mean of $80.78 per patient who filled a prescription. CONCLUSION: Adult ETD is frequently treated with several medication classes by a variety of provider types. Understanding the potential adverse effects and cost associated with these practices should be a priority.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. McCoul ED, Weinreich HM, Mulder H, et al. Health Care Utilization and Prescribing Patterns for Adult Eustachian Tube Dysfunction. Otolaryngol Head Neck Surg. 2019. PMID: 30721112. doi:10.1177/0194599819826959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。